Folgen
Omar Jawdat
Omar Jawdat
Assistant Professor of Neurology, University of Kansas Medical Center
Bestätigte E-Mail-Adresse bei kumc.edu
Titel
Zitiert von
Zitiert von
Jahr
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
JF Howard, V Bril, T Vu, C Karam, S Peric, T Margania, H Murai, ...
The Lancet Neurology 20 (7), 526-536, 2021
2772021
Pompe disease: literature review and case series
M Dasouki, O Jawdat, O Almadhoun, M Pasnoor, AL McVey, ...
Neurologic clinics 32 (3), 751-776, 2014
1592014
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression
MD Weiss, EA Macklin, Z Simmons, AS Knox, DJ Greenblatt, N Atassi, ...
Neurology 86 (16), 1474-1481, 2016
982016
Amyotrophic lateral sclerosis regional variants (brachial amyotrophic diplegia, leg amyotrophic diplegia, and isolated bulbar amyotrophic lateral sclerosis)
O Jawdat, JM Statland, RJ Barohn, JS Katz, MM Dimachkie
Neurologic clinics 33 (4), 775-785, 2015
582015
Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis
Q Gang, C Bettencourt, PM Machado, S Brady, JL Holton, AM Pittman, ...
Neurobiology of aging 47, 218. e1-218. e9, 2016
542016
Adaptive platform trials to transform amyotrophic lateral sclerosis therapy development
S Paganoni, JD Berry, M Quintana, E Macklin, BR Saville, MA Detry, ...
Annals of neurology 91 (2), 165-175, 2022
502022
Patient assisted intervention for neuropathy: comparison of treatment in real life situations (PAIN-CONTRoLS): Bayesian adaptive comparative effectiveness randomized trial
RJ Barohn, B Gajewski, M Pasnoor, A Brown, LL Herbelin, KS Kimminau, ...
JAMA neurology 78 (1), 68-76, 2021
292021
A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization
AR Brown, BJ Gajewski, LS Aaronson, DP Mudaranthakam, SL Hunt, ...
Trials 17, 1-9, 2016
252016
Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale
H Mitsumoto, C Chiuzan, M Gilmore, Y Zhang, Z Simmons, S Paganoni, ...
Muscle & nerve 61 (2), 163-172, 2020
192020
Using automated electronic medical record data extraction to model ALS survival and progression
AG Karanevich, LJ Weisbrod, O Jawdat, RJ Barohn, BJ Gajewski, J He, ...
BMC neurology 18, 1-7, 2018
182018
An instrumented timed up and go in facioscapulohumeral muscular dystrophy
J Huisinga, A Bruetsch, A Mccalley, M Currence, L Herbelin, O Jawdat, ...
Muscle & nerve 57 (3), 503-506, 2018
142018
Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysis
G Ramdharry, J Morrow, S Hudgens, I Skorupinska, K Gwathmey, ...
Muscle & Nerve 60 (2), 161-168, 2019
122019
Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord
SK Tungtur, HM Wilkins, RS Rogers, Y Badawi, JM Sage, A Agbas, ...
Scientific reports 11 (1), 11051, 2021
92021
Use of capillary electrophoresis immunoassay to search for potential biomarkers of amyotrophic lateral sclerosis in human platelets
JM Sage, LS Hall, A McVey, RJ Barohn, JM Statland, O Jawdat, ...
JoVE (Journal of Visualized Experiments), e60638, 2020
82020
Satisfactory response with achieving maintenance low-dose prednisone in generalized myasthenia gravis
AR Abuzinadah, D Jabari, O Jawdat, M Pasnoor, M Glenn, L Herbelin, ...
Journal of clinical neuromuscular disease 20 (2), 49-59, 2018
82018
Less is more in diabetic neuropathy diagnosis: comparison of quantitative sudomotor axon reflex and skin biopsy
AR Abuzinadah, P Kluding, D Wright, L D'Silva, J Ryals, B Hendry, ...
Journal of clinical neuromuscular disease 19 (1), 5-11, 2017
72017
A novel physiologic marker of bulbar motor involvement in amyotrophic lateral sclerosis: Jaw muscle synergy
P Rong, O Jawdat
Clinical Neurophysiology 132 (1), 94-103, 2021
62021
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
PM Machado, MP McDermott, T Blaettler, C Sundgreen, AA Amato, ...
The Lancet Neurology 22 (10), 900-911, 2023
52023
Preface: promoting research in PLS: current knowledge and future challenges
H Mitsumoto, MR Turner, all Delegates of the PLS Conference, ...
Amyotrophic lateral sclerosis and frontotemporal degeneration 21 (sup1), 1-2, 2020
52020
Amyloid myopathy as an inclusion body myositis mimic
A Heim, A Hamasaki, M Dimachkie, M Pasnoor, O Jawdat, J Statland, ...
RRNMF Neuromuscular Journal 1 (4), 28-32, 2020
4*2020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20